Sign in

You're signed outSign in or to get full access.

Gary Kreitzer

Vice Chairman at INNOVATIVE INDUSTRIAL PROPERTIES
Board

About Gary Kreitzer

Gary Kreitzer (age 70) is IIPR’s independent vice chairman and co‑founder, serving on the board since formation in June 2016. A California‑licensed attorney, he brings 40 years of real estate/REIT legal and governance experience, including senior legal roles and directorships at BioMed Realty and Alexandria Real Estate. He holds a BA from UC San Diego and a JD (with honors) from the University of San Francisco. The board affirms his independence (co‑founder but never an employee) and notes 100% board and committee meeting attendance in 2024 .

Past Roles

OrganizationRoleTenureCommittees/Impact
BioMed Realty Trust (NYSE: BMR; sold 2016)General Counsel; Director; EVPGC: 2004–Aug 2012; Director: until Jan 2016; EVP: until Feb 2017Helped build NYSE‑listed REIT; governance/legal leadership
Bernardo Property AdvisorsGeneral Counsel; Director; EVPDec 1998–Aug 2004Predecessor to BioMed; executive roles
Alexandria Real Estate (NYSE: ARE)Senior VP & In‑House Counsel; Co‑founder1994–Dec 1998Foundational REIT experience
Seawest Energy CorporationIn‑House Counsel & VP1990–1994Alternative energy facilities development
The Christiana Companies, Inc. (public)In‑House Counsel, Secretary, VP1982–1989Investment/real estate development company

External Roles

OrganizationRoleTenureNotes
IQHQ, Inc. (private life science RE co.)Vice Chairman; Compensation Committee MemberDec 2018–Dec 2024Governance and comp oversight

Board Governance

  • Independence: Independent under NYSE standards; co‑founder, never an employee; all committee members are independent .
  • Committee assignments: Compensation Committee Chair; Audit Committee Member; Nominating & Corporate Governance Committee Member .
  • Attendance: 100% attendance at six board meetings and all served committees in 2024; regular executive sessions of independent directors .
  • Board leadership: As vice chairman, serves as liaison, presides when the executive chairman is absent, and may call/set agenda for independent director meetings .
  • Policies: Anti‑hedging and anti‑pledging; formal clawback; minimum stock ownership for directors; regular board/committee/director evaluations .

Fixed Compensation (Director)

Component (FY2024)AmountDetails
Cash retainer$150,000Vice Chairman retainer (vs. standard $75,000 for other directors)
Chair fee (Compensation Committee)$5,000Additional annual retainer for committee chair
Total cash fees$155,000Sum of vice chair plus chair fee
Equity grant (Restricted Stock/RSUs)$200,099Grant date fair value per ASC 718
Shares granted1,770 shares (restricted stock)Vest in full on May 15, 2025
Total$355,099Cash + equity
  • Director equity award structure: Annual grants of restricted stock/RSUs vest 1 year from grant; directors may defer settlement under the NQDC Plan .

Performance Compensation (Director)

ElementMetric(s)FY2024 OutcomeVesting/Terms
Annual director equityTime‑based onlyNot performance‑basedOne‑year cliff vest; RSUs/restricted stock; deferral optional

No director options or performance‑conditioned director equity are disclosed for 2024; director compensation is a mix of cash retainers and time‑vested stock/RSUs .

Other Directorships & Interlocks

CompanyTypeRoleStatus/Period
BioMed Realty Trust (NYSE: BMR)Public REITDirector; GC; EVPHistorical; director until Jan 2016; EVP until Feb 2017
Alexandria Real Estate (NYSE: ARE)Public REITSenior VP & Counsel; Co‑founderHistorical (1994–1998)
IQHQ, Inc.Private REVice Chairman; Comp CommitteeDec 2018–Dec 2024
  • Compensation committee interlocks: None; comp committee comprised solely of independent, non‑employee directors in 2024 .

Expertise & Qualifications

  • REITs/real estate: Deep experience across multiple NYSE‑listed REITs (ARE, BMR) and private RE platforms .
  • Legal/regulatory: California Bar; decades as GC/SVP; strong corporate governance credentials .
  • Capital markets/governance: Board leadership, compensation oversight, and risk management experience .

Equity Ownership

ItemValueNotes
Beneficial ownership (shares)43,958Restricted stock held directly; voting/dividend rights; vests May 15, 2025
Ownership % of shares outstanding<1%As of 28,011,229 outstanding shares (Apr 14, 2025)
Anti‑hedge/pledgeProhibitedPolicy bans hedging and pledging company stock
Director ownership guideline≥5x annual cash retainerIIPR policy for non‑employee directors
Guideline threshold (Gary)$750,0005 × $150,000 vice chair retainer
Approx. value of holdings (12/31/2024)~$2.93 million43,958 × $66.64 closing price on 12/31/2024 → ~$2,928,9xx; exceeds guideline

Governance Assessment

  • Positives: Independent vice chairman with 100% attendance; chairs compensation committee and serves on audit and nominating committees; robust anti‑hedging/pledging and clawback; strong director ownership guideline; all committees comprised of independent directors .
  • Alignment: Material personal equity stake and compliance with ownership guidelines enhance alignment; equity grants are time‑vested, reinforcing long‑term orientation .
  • Engagement: Board conducted outreach after a lower 2024 say‑on‑pay (73% support) and implemented formulaic metrics in the executive annual incentive plan—evidence of responsiveness by the comp committee led by Kreitzer .
  • Conflicts/related party exposure: No related‑party transactions disclosed involving Kreitzer; company reimburses the executive chairman’s privately owned aircraft under audit committee‑approved policy with annual cap—oversight falls within audit committee remit where Kreitzer is a member (monitoring RPTs, cybersecurity, etc.) .
  • RED FLAGS: None disclosed specific to Kreitzer (no hedging/pledging; no interlocks; independent status maintained despite co‑founder role) .